The Moscow Times on MSN
St. Petersburg opens first 2 stations on new metro line
The city of St. Petersburg on Friday opened two metro stations that form the initial segment of a new metro line. The ...
No one's crossed the finishing line yet, but drug developer Nyrada is leading the Great Biotech Regatta of 2025 with close to ...
China NMPA grants marketing approval for Innovent Biologics' Tyvyt, a CTLA-4 monoclonal antibody: San Francisco Saturday, December 27, 2025, 16:00 Hrs [IST] Innovent Biologics Inc ...
(11/15 participants) improved on the Overall Cutaneous Venous Malformations Investigator Global Assessment (Overall ...
Firmonertinib has the potential to redefine first-line treatment in this underserved population as a once daily, oral, brain-penetrant, ...
In line with its expansion into institutional-grade infrastructure services, Crouton Digital has initiated the process of ...
In the last Fierce Pharma Asia weekly news roundup of 2025, Daiichi Sankyo scored a key FDA approval for ...
The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY ® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult ...
SoundHound AI's recent financial performance has been impressive. In the first nine months of fiscal 2025, revenue jumped 127% year over year to $114 million. While not yet profitable, management ...
End-of-Phase 2 interactions with FDA complete; scientific advice received from EMA – – Company expects to dose first patient in global Phase 3 registrational trial, MAPKeeper 301, in mid-2026 – – ...
EMA validates Type II Variation marketing authorization application of Datroway as first-line treatment for patients with metastatic TNBC who are not candidates for immunotherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results